Product

IASOflu

iasoflu 1

Marketing Authorizations

Country
Product Name
MA number
Date of registration
PDF
PDF
France
IASOflu
34009 578 426 5 9 (15mL) 34009 573 228 0 9 (25mL)
21.07.2015
Austria
IASOflu
4-00043
20.10.2010
No data was found
Belgium fr
IASONfluoride
BE379102 (15ml) BE379111 (25ml)
11.10.2010
No data was found
No data was found
Bulgaria
IASOflu
II-11061/ 22.10.2010
22.10.2010
No data was found
No data was found
No data was found
No data was found
Germany
IASOflu
76609.00.00
22.11.2010
No data was found
Hungary
IASOflu
OGYI-T-21705/01 (15ml) OGYI-T-21705/02 (25ml)
28.04.2011
Italy
IASONfluoride
040986010 (15mL) 040986022 (25mL)
14.10.2013
No data was found
Luxemburg
IASOflu
1523/11050028 (15 ml) 1523/11050028 (25 ml)
17.06.2011 (15ml) 06.07.2011 (25ml)
No data was found
No data was found
Poland
IASOflu
17727
20.01.2011
No data was found
Romania
IASOflu
8035/2015/01-02
13.05.2011
Slovakia
IASOflu
88/0832/10-S
31.01.2011
Slowenia
IASOflu
H/11/00747/001 (15mL) H/11/00747/002 (25mL)
24.02.2012

Product sheets

Name
Download
IASOflu

Sodium fluoride (¹⁸F) positron emission tomography (PET) is indicated for functional imaging in diseases where abnormally altered osteogenic activity is the diagnostic target.

Therapeutic indications

The following indications have been particularly documented:

  • Detection and localisation of bone metastases in case of cancer in adults.
  • As an aid in the evaluation of back pain of ambiguous origin in adults, when conventional imaging modalities are not conclusive.
  • As an aid in the detection of the presence of bone lesions related to suspected child abuse.
    This medicinal product is for diagnostic use only.

Therapeutic indications. This medicinal product is for diagnostic use only.

More innovative
products

01

Arrow Right

02

Arrow Right

04

Arrow Right

Do you want to know more about our products?

For inquiries please contact us, we will be happy to assist you!

Scroll to Top